ReadyCell Partnering in China

china partnerships
Communications Department
1 March 2013

Developing new international partnerships

After different contacts along 2013, last month ReadyCell visited several companies during a Chinese tour. With the aim to promote its implantation in the Asian market, and being a hub for R&D and CRO services, Shanghai and Beijing were the cities chosen for this partnering trip.

ReadyCell representatives met CEOs, CSOs and ADME Directors from key Chinese companies as Wuxi App Tec, Joinn Laboratories, Shanghai Medicilon and PharmaLegacy. Thanks to ReadyCell strategic partner Link China Pharma, several top Chinese CROs are actually evaluating Ready-to-Use kits for their implantation in their Permeability assays.

Implantation of ReadyCell kits in Asia (China and India) as regular supplier is expected to be set up for 2014 Q3, as part of the company strategic plan for this year.

Related posts

Job offer: Junior Account Manager

Job offer: Junior Account Manager

ReadyCell is a biotechnological company focused on providing superior cell-based in vitro plates for the ADME-Tox market segment. Our innovative products facilitate and streamline drug discovery and medical research studies thanks to a revolutionary and patented...

Get to know our talented women from Readycell

Get to know our talented women from Readycell

In honor of the International Day of Women and Girls in Science, we present a series of videos featuring insights from our team members that explore the diverse experiences and perspectives of the talented women at ReadyCell.